Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will participate in a fireside chat at the Oppenheimer 25th Annual ...

After 45 years in space, NASA’s Voyager 1 & 2 are still making history! These legendary probes have traveled beyond our solar ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

West Long Branch, United States - February 03, 2025 A dramatic rescue unfolded on February 3 afternoon when a New Jersey ...

Drive the future at NAFA I&E 2025 — ride along in the latest EVs on an indoor track, hit the road with the return of Ride & ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Lucid Group, Inc. (NASDAQ: LCID), maker of the world's most advanced electric vehicles, announced that the Lucid Gravity ...

Three companies behind well-known Gold Coast restaurants are in liquidation with hefty debts – but two of the venues have ...

Learn more about whether Biogen Inc. or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Starforge Systems can build a capable gaming PC, that's for sure. But is notable aesthetic customization enough to set this ...

Thirty years ago today, 'Phage' introduced us to the Vidiians, giving Star Trek one of its best body horror scares wrapped in layers of tragedy.

In its first Spider-Man game, developer Insomniac already got the most important thing right: the feel of being super-powered ...